Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI-Powered robot could personalize stroke rehab

NCT ID NCT07199322

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence system can help therapists set better rehab exercises for a robotic arm trainer used by stroke patients. One hundred adults who had a stroke within the last six months will receive either AI-guided or therapist-guided robotic therapy. The goal is to see if the AI approach improves arm movement, daily activities, and quality of life more than standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MOTORE robotic device with AI decision-support software
What this could lead to
If it works, this could make robotic rehab more personalized and effective, helping stroke survivors regain arm function faster.
What could go wrong
This is an early-stage study with only 100 participants, so results may not apply to everyone. The AI support may not outperform standard therapist-guided rehab.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of ischemic or hemorrhagic stroke confirmed by Computed Tomography (CT) or Magnetic Resonance Imaging (MRI); * Age between 18 and 85 years; * Time since stroke less than six months; * Mild to severe upper limb impairment (Fugl-Meyer Assessment for Upper Extremity (FMA-UE) ≤ 58). Exclusion Criteria: * Behavioral or cognitive disorders and/or reduced compliance; * Severe spasticity or hypertonia in the affected limb (Modified Ashworth Scale (MAS) \> 3); * Severe visual impairments; * Concurrent participation in another clinical trial for upper limb rehabilitation following stroke; * Refusal to provide written informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhagic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fondazione Don Carlo Gnocchi, Centro Gala

    Acerenza, PZ, 85011, Italy

  • Fondazione Don Carlo Gnocchi, Centro Santa Maria ai Colli - Presidio Sanitario Ausiliatrice

    Torino, TO, 10133, Italy

  • Fondazione Don Carlo Gnocchi, Centro Santa Maria della Provvidenza

    Roma, RM, 00166, Italy

  • Fondazione Don Carlo Gnocchi, Centro Spalenza

    Rovato, BS, 25038, Italy

  • Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo

    Sant'Angelo dei Lombardi, AV, 83054, Italy

  • Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo

    Tricarico, Mount, 75019, Italy

  • Fondazione Don Carlo Gnocchi, Santa Maria dei Poveri Polo Riabilitativo del Levante ligure

    La Spezia, SP, 19125, Italy

  • Fondazione Policlinico Universitario Campus Bio-Medico

    Roma, RM, 00128, Italy

  • IRCSS Fondazione Don Carlo Gnocchi

    Florence, FI, 50143, Italy

  • Scuola Superiore Sant'Anna

    Pisa, PI, 56127, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.